4//SEC Filing
THERAGENICS CORP 4
Accession 0000795551-13-000017
CIK 0000795551operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 5:28 PM ET
Size
15.0 KB
Accession
0000795551-13-000017
Insider Transaction Report
Form 4
SAUNDERS PETER A A
Director
Transactions
- Disposition to Issuer
Common Stock
2013-10-29$2.20/sh−139,000$305,800→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2013-10-29$1.02/sh−5,000$5,100→ 0 totalExercise: $1.02Exp: 2019-05-14→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-10-29$1.33/sh−5,000$6,650→ 0 totalExercise: $1.33Exp: 2020-05-13→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Shares of common stock which were disposed of in exchange for the right to receive $2.20 per share in cash pursuant to the Agreement and Plan of Merger, dated August 2, 2013 (as it may be amended, the "Merger Agreement"), by and between Juniper Acquisition Corporation (the "Purchaser") and Theragenics Corporation (the "Company") providing for the merger of Purchaser with and into the Company (the "Merger").
- [F2]The stock options, which provided for vesting in three equal annual installments beginning on 5-14-2010 was cancelled in exchange for the right to receive the difference between the exercise price of the option and $2.20 per share in cash pursuant to the Merger Agreement.
- [F3]The stock options, which provided for vesting in three equal annual installments beginning on 5-13-2011 was cancelled in exchange for the right to receive the difference between the exercise price of the option and $2.20 per share in cash pursuant to the Merger Agreement.
Issuer
THERAGENICS CORP
CIK 0000795551
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000795551
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 5:28 PM ET
- Size
- 15.0 KB